{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:11:51Z","timestamp":1790273511190,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.intimp.2026.117379","type":"journal-article","created":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:26:35Z","timestamp":1789259195000},"page":"117379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Perfluorodecanoic acid (PFDA) exposure, through stabilizing HIF-1\u03b1 to induce VEGF\/VEGFR2 autocrine signaling, promotes colorectal cancer cell proliferation"],"prefix":"10.1016","volume":"189","author":[{"given":"Li","family":"Na","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"YuanFang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yawei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"ZhiYu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suo","family":"SiYuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117379_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jece.2024.114990","article-title":"Electrochemical methods for treatment of per-and polyfluoroalkyl substances (PFAS): a review","volume":"13","author":"Tan","year":"2025","journal-title":"J. Environ. Chem. Eng."},{"key":"10.1016\/j.intimp.2026.117379_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.178240","article-title":"A systematic review for non-targeted analysis of per-and polyfluoroalkyl substances (PFAS)","volume":"960","author":"Megson","year":"2025","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.intimp.2026.117379_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2025.127036","article-title":"Per-and polyfluoroalkyl substances (PFAS) contamination in agriculture and its potential conflict with circular economy","author":"Islam","year":"2025","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.intimp.2026.117379_bb0020","first-page":"1","article-title":"Associations between per-and polyfluoroalkyl substances (PFAS) and county-level cancer incidence between 2016 and 2021 and incident cancer burden attributable to PFAS in drinking water in the United States","author":"Li","year":"2025","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"10.1016\/j.intimp.2026.117379_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.168618","article-title":"Biotransformation of per-and polyfluoroalkyl substances (PFAS) in organisms","author":"Dai","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.intimp.2026.117379_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/toxics13070541","article-title":"Application of a dynamic exposure population toxicokinetic model for perfluorooctane sulfonic acid (PFOS) and extension to perfluorodecanoic acid (PFDA) at a North American beef cattle farm with a history of biosolids land application","volume":"13","author":"Astmann","year":"2025","journal-title":"Toxics"},{"key":"10.1016\/j.intimp.2026.117379_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2026.144837","article-title":"Electrokinetic mobilization of PFAS in soils: linking head group and chain length to remediation efficiency","volume":"396","author":"Dhulia","year":"2026","journal-title":"Chemosphere"},{"key":"10.1016\/j.intimp.2026.117379_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2023.153719","article-title":"Distinct bile acid alterations in response to a single administration of PFOA and PFDA in mice","volume":"502","author":"Yu","year":"2024","journal-title":"Toxicology"},{"key":"10.1016\/j.intimp.2026.117379_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.108405","article-title":"Overall and individual associations between per-and polyfluoroalkyl substances and liver function indices and the metabolic mechanism","volume":"183","author":"Chen","year":"2024","journal-title":"Environ. Int."},{"key":"10.1016\/j.intimp.2026.117379_bb0050","doi-asserted-by":"crossref","first-page":"19119","DOI":"10.1021\/acs.est.5c04320","article-title":"Perfluorodecanoic acid (PFDA) disrupts immune regulation via the toll-like receptor signaling pathway in zebrafish","volume":"59","author":"Wang","year":"2025","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.intimp.2026.117379_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2024.125595","article-title":"Perfluorodecanoic acid (PFDA) increases oxidative stress through inhibition of mitochondrial \u03b2-oxidation","volume":"367","author":"Widhalm","year":"2025","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.intimp.2026.117379_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.176786","article-title":"Environmentally relevant level of PFDA exacerbates intestinal inflammation by activating the cGAS\/STING\/NF-\u03baB signaling pathway","volume":"954","author":"Cui","year":"2024","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.intimp.2026.117379_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.115503","article-title":"Low dose PFDA induces DNA damage and DNA repair inhibition by promoting nuclear cGAS accumulation in ovarian epithelial cells","volume":"265","author":"Qin","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.intimp.2026.117379_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2024.142758","article-title":"PFDA promotes cancer metastasis through macrophage M2 polarization mediated by Wnt\/\u03b2-catenin signaling","volume":"362","author":"Cui","year":"2024","journal-title":"Chemosphere"},{"key":"10.1016\/j.intimp.2026.117379_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2023.139411","article-title":"Per-and polyfluoroalkyl substances and the associated thyroid cancer risk: a case-control study in China","volume":"337","author":"Li","year":"2023","journal-title":"Chemosphere"},{"key":"10.1016\/j.intimp.2026.117379_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113520","article-title":"Perfluorodecanoic acid promotes adipogenesis via NLRP3 inflammasome-mediated pathway in HepG2 and 3T3-L1 cells","volume":"171","author":"Wang","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.intimp.2026.117379_bb0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/jcm13010040","article-title":"Colorectal cancer: current updates and future perspectives","volume":"13","author":"Marcellinaro","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2026.117379_bb0090","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev-pathmechdis-031521-041113","article-title":"Metabolism and colorectal cancer","volume":"18","author":"Sedlak","year":"2023","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.intimp.2026.117379_bb0095","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.21873\/anticanres.17105","article-title":"Tumor infiltrating effector regulatory T cells express VEGF receptor 2 in patients with colorectal cancer","volume":"44","author":"Tsumuraya","year":"2024","journal-title":"Anticancer Res."},{"key":"10.1016\/j.intimp.2026.117379_bb0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000521584","article-title":"VEGF-independent angiogenic factors: beyond VEGF\/VEGFR2 signaling","volume":"59","author":"Eguchi","year":"2022","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.intimp.2026.117379_bb0105","article-title":"Perfluorodecanoic acid (PFDA) induces oxidative stress and autophagy dysregulation in HGrC1 cells","author":"Barakat","year":"2025","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.intimp.2026.117379_bb0110","article-title":"Hypoxia-inducible factor 1-alpha (HIF-1\u03b1) and cancer: mechanisms of tumor hypoxia and therapeutic targeting","volume":"16","author":"Basheeruddin","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.intimp.2026.117379_bb0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","article-title":"Molecular mechanisms and future implications of VEGF\/VEGFR in cancer therapy","volume":"29","author":"Patel","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.117379_bb0120","doi-asserted-by":"crossref","first-page":"15585","DOI":"10.3390\/ijms232415585","article-title":"The VEGF\/VEGFR axis revisited: implications for cancer therapy","volume":"23","author":"Mabeta","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117379_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116685","article-title":"Wnt\/\u03b2-catenin signalling, epithelial-mesenchymal transition and crosslink signalling in colorectal cancer cells","volume":"175","author":"Sun","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.intimp.2026.117379_bb0130","article-title":"Redox regulation of cancer stem cells: biology and therapeutic implications","volume":"3","author":"Du","year":"2024","journal-title":"MedComm-Oncol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926012269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926012269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:53:42Z","timestamp":1790272422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926012269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":26,"alternative-id":["S1567576926012269"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117379","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perfluorodecanoic acid (PFDA) exposure, through stabilizing HIF-1\u03b1 to induce VEGF\/VEGFR2 autocrine signaling, promotes colorectal cancer cell proliferation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117379"}}